Day: June 7, 2021

CAMBRIDGE, Mass., June 07, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced the grant of an inducement award to its newly appointed Chief Regulatory Officer, Dr. Iman Barilero. The grant was approved by a majority of the independent directors of the Company on May 5, 2021 as an inducement material to Dr. Barilero entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The inducement grant to Dr. Barilero consisted of an option to purchase up to 180,000 shares of common stock. The option has an exercise price of $3.75 per share, the closing price per share of Solid Biosciences’ common stock as reported by Nasdaq on June 1, 2021. The option has a ten-year...

MONTREAL, June 07, 2021 (GLOBE NEWSWIRE) — MONARCH MINING CORPORATION (“Monarch” or the “Corporation”) (TSX: GBAR) (OTCQX: GBARF) is pleased to announce that it has received confirmation from the Depository Trust Company (“DTC”) that its common shares are now eligible for electronic clearing and settlement through DTC in the United States. Monarch currently trades on the OTCQX under the ticker symbol GBARF. DTC is a subsidiary of The Depository Trust & Clearing Corp. DTC manages the electronic clearing and settlement of publicly traded companies in the United States. Securities that are eligible to be electronically cleared and settled through DTC are considered DTC eligible. This electronic method of clearing securities accelerates the settlement process for investors and brokers, enabling a security to be traded over a much...

VANCOUVER, British Columbia, June 07, 2021 (GLOBE NEWSWIRE) — Amerigo Resources Ltd. (TSX: ARG; ARREF:OTC) (“Amerigo” or the “Company”) is pleased to announce the appointment of Margot Naudie and David Thomas to the Company’s board of directors. Margot Naudie is a seasoned 25-year capital markets professional with global investment expertise as a Senior Portfolio Manager for long-only and long/short North American and global natural resource portfolios. She has held senior roles at leading multi-billion-dollar asset management firms, including TD Asset Management, Marret Asset Management, and CPP Investment Board. Margot was cited as a Brendan Wood TopGun Investment Mind (Platinum) for five consecutive years. She is an active and engaged Independent Director on public and private company boards, where she acts as Lead Director,...

ROCKVILLE, Md., June 07, 2021 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that it has submitted an updated 510(k) summary document to the U.S. FDA for its Acuitas AMR Gene Panel for Isolates. This document incorporates all of the FDA’s requested updates to various key documents such as the Package Insert, Electronic User Guide, and Operator Manual. Consistent with the FDA’s previously communicated timeline, the FDA provided substantive feedback on all of these key documents by the end of May. The FDA previously informed OpGen that it intends to complete its review by the end of August 2021, but that it cannot commit to a timeline and that such timeline can be affected by various...

NOIDA, India and JOHNS CREEK, Ga., June 07, 2021 (GLOBE NEWSWIRE) — EbixCash Private Limited, a subsidiary of Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of On-Demand software and E-commerce services to the insurance, financial, healthcare and e-learning industries today announced the appointment of Mr. S Ravi, as a new independent director to the EbixCash Board. Ravi brings a vast repertoire of experience across banks, financial institutions, insurance companies, tourism industry, stock exchanges and asset management areas – having held Board positions in eminent organizations across these sectors. Ravi is presently serving as the Chairman and Director of Tourism Finance Corporation of India Ltd. – the premier government owned financial Institution, set-up to promote tourism in India. He also presently serves...

CAMBRIDGE, Mass., June 07, 2021 (GLOBE NEWSWIRE) — Solid Biosciences Inc. (Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy (Duchenne), today announced that Dr. Iman Barilero has joined the Company as Chief Regulatory Officer, effective June 1, 2021. Dr. Barilero brings three decades of experience as a strategic executive in the healthcare industry, successfully designing innovative and integrated regulatory pathways that gained regulatory approvals for new molecular entities in various areas of unmet medical needs across all phases of development in the U.S., EU, Switzerland, China, Japan and Brazil. “Dr. Barilero comes to us with a wealth of experience in drug development and regulatory science, and the combination of her expert knowledge and passion to impact patients’...

TORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Probe Metals Inc. (TSX-V: PRB) (OTCQB: PROBF) (“Probe” or the “Company”) is very pleased to announce the appointment of Ms. Aleksandra (Sasha) Bukacheva to its board of directors, effective immediately. Ms. Bukacheva is a capital markets and finance professional focused on the metals and mining industry. She was most recently an independent director at Battle North Gold Corporation before it was acquired by Evolution Mining Limited. Prior to that she was Executive Vice President, Corporate Development of Element 29 Resources Inc., a junior explorer focused on copper resource development in Peru, as well as a director of Gippsland Prospecting Pty. Ltd., a private Australian company which was sold to Battery Minerals Limited in October 2020. Sasha brings with her a wealth of capital markets...

Figure 1Twin Hills brownfields exploration program (results shown in light green are assays reported previously)Figure 2Twin Hills West (THW) – Terminal 1 target, shown in red outline.Figure 3Regional Geology of the Dobbelsberg & Navachab Domes, Osino Calcrete Sampling & Bedrock Drilling AreaHighlights14 brownfields targets previously identified in the 2020 IP survey have now been drill-tested 4 of the targets yielded significant gold mineralization, immediate follow-up DD drilling planned Two completely new zones of mineralization discovered at Clouds North and Terminal 1 Drill intercepts returned from the brownfields targets include:OKD175 – 48m @ 0.79g/t (116-164m) incl. 12m @ 1.93g/t (Twin Hills West (“THW“)) OKR264 – 24m @ 1.00g/t incl. 9m @ 1.96g/t (Clouds West) OKR259...

Exhibit 1 – Compilation map and 2021 drill planExhibit 1 – Compilation map and 2021 drill planExhibit 2 – Table of Diamond Drill ResultsExhibit 2 – Table of Diamond Drill ResultsExhibit 3 – 2018 and 2021 MAG-VLF Survey Area, Lingman Lake propertyExhibit 3 – 2018 and 2021 MAG-VLF Survey Area, Lingman Lake propertyTORONTO, June 07, 2021 (GLOBE NEWSWIRE) — Signature Resources Ltd. (TSXV: SGU, OTCQB: SGGTF, FSE 3S3) (“Signature” or the “Company”) is pleased to announce the first three diamond drill holes (515 metres) of its ongoing 15 diamond drill hole (3,260 metres) winter-spring drill campaign at its 100% owned Lingman Lake Gold Project (“Project”). Drilling was designed to expand the known envelope of mineralization on the western side of the diabase dike...

NIH Researchers Contend “Tempol may be a Promising Oral Antiviral Treatment for COVID-19” Research Team Intends to Conduct Additional Studies, Including a Prospective Clinical Study for Tempol in the Treatment of COVID-19 SAN DIEGO, June 07, 2021 (GLOBE NEWSWIRE) — Adamis Pharmaceuticals Corporation (Nasdaq: ADMP) today highlighted that the National Institutes of Health (NIH) has identified its experimental drug, Tempol, as a potentially potent antiviral for COVID-19. According to a study of cell cultures conducted by NIH researchers, Tempol demonstrated an ability to limit SARS-CoV-2 infection by impairing the activity of a viral enzyme known as RNA replicase. The NIH researchers also found that Tempol “doses used in their antiviral studies could be likely achieved in tissues that are the primary targets for the virus.”1 The June...